Meta AnalysisID 6042
Back to Browse当归四逆汤治疗糖尿病周围神经病变：随机对照试验的系统评价和Meta分析
CRD42020161585
Is Danggui Sini Decoction (DSD) beneficial for diabetic peripheral neuropathy (DPN)?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, literature, qherb, pherb, evidence, and monographs. Click chips to show or hide node types.
Click a node to open
Links: 1
Arranging relationship network...
At a Glance
Curated fields selected for quick interpretation of this Meta Analysis record.
- CRD ID
- CRD42020161585
- Country
- China
- Review Stage
- Review Ongoing
Review Identity
Review registration and scope.
- CRD ID
- CRD42020161585
- Review Stage
- Review Ongoing
- Country
- China
- Language
- English
Review Question
Population, intervention, comparator, and outcomes.
- Review Question
- Is Danggui Sini Decoction (DSD) beneficial for diabetic peripheral neuropathy (DPN)?
- Condition
- Diabetic peripheral neuropathy (DPN) is a common chronic complication of diabetes. It is hidden and has a significant impact on the quality of life of patients. Early identification and treatment of DPN is of great significance for patients' prognosis.
- Participant
- Adults with clinically diagnosed diabetic peripheral neuropathy.
- Intervention
- Danggui Sini Decoction (DSD) is a classical prescription described in Shanghan Zabing Lun, written by Zhang Zhongjing during the Han dynasty. Studies that used any type of DSD or a modified DSD are included, as are studies comparing the effects of DSD alone or combined with conventional medication (NSAID or OCP) to the effects of conventional medicine alone. A modified DSD is defined by practitioners as a DSD with no more than one of the original herbs, but which had the same action as the original DSD formula. We include all forms of this medication, such as extracts, tablets, capsules, pills, powders, and injections. Studies examining DSD combined with other herbal decoctions or with other types of therapy are excluded. Trials in which the DSD is used as an adjunct to conventional treatment, usual care, or standard care are included if the control group received the same concomitant treatment as the DSD group.
- Comparator Control
- No current/recent DSD use.
- Main Outcome
- Clinical efficacy. Measures of effect None
- Study Method
- Meta-analysis, Systematic review
Registration Timeline
Submission and completion dates.
- First Submission Date
- 2019-12-08
- Registration Date
- 2020-04-28
- Anticipated Start Date
- 2019-12-18
- Anticipated Completion Date
- 2020-05-23